{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:13:37Z","timestamp":1791994417567,"version":"4.4.0"},"reference-count":21,"publisher":"Galenos Yayinevi","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"DOI":"10.4274\/tjo.galenos.2025.19940","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T10:44:31Z","timestamp":1755773071000},"page":"193-199","source":"Crossref","is-referenced-by-count":3,"title":["Macular Telangiectasia Type 2: Long-Term Disease Progression and Management of Complications"],"prefix":"10.4274","volume":"55","author":[{"given":"Merve","family":"\u00d6zbek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zg\u00fcr","family":"Artunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcmeysa","family":"Ko\u00e7ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130lker","family":"Ho\u015fver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Metehan","family":"\u015eim\u015fek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1001\/archopht.1982.01030030773010","article-title":"Idiopathic juxtafoveolar retinal telangiectasis","volume":"100","author":"JD","year":"1982","unstructured":"1. Gass JD, Oyakawa RT. Idiopathic juxtafoveolar retinal telangiectasis. Arch Ophthalmol. 1982;100:769-780.","journal-title":"Arch Ophthalmol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"18954","DOI":"10.1038\/s41598-023-46394-4","article-title":"Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients","volume":"13","author":"Totsuka","year":"2023","unstructured":"2. Totsuka K, Aoki S, Arai T, Kitamoto K, Azuma K, Fujino R, Inoue T, Obata R. Longitudinal anatomical and visual outcome of macular telangiectasia type 2 in Asian patients. Sci Rep. 2023;13:18954.","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100261","DOI":"10.1016\/j.xops.2022.100261","article-title":"Macular telangiectasia type 2: a classification system using multimodal imaging mactel project report number 10","volume":"3","author":"Chew","year":"2022","unstructured":"3. Chew EY, Peto T, Clemons TE, Sallo FB, Pauleikhoff D, Leung I, Jaffe GJ, Heeren TFC, Egan CA, Charbel Issa P, Balaskas K, Holz FG, Gaudric A, Bird AC, Friedlander M. Macular telangiectasia type 2: a classification system using multimodal imaging mactel project report number 10. Ophthalmol Sci. 2022;3:100261.","journal-title":"Ophthalmol Sci"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/08820538.2021.1929347","article-title":"Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel type 2 in 82 Eyes","volume":"37","author":"Marsonia","year":"2022","unstructured":"4. Marsonia K, Kiran Chandra K, Ali MH, Chhablani J, Narayanan R. Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel type 2 in 82 Eyes. Semin Ophthalmol. 2022;37:136-141.","journal-title":"Semin Ophthalmol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/IAE.0b013e3182625c1d","article-title":"Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2","volume":"32","author":"Narayanan","year":"2012","unstructured":"5. Narayanan R, Chhablani J, Sinha M, Dave V, Tyagi M, Pappuru RR, Kuppermann BD. Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2. Retina. 2012;32:2001-2005.","journal-title":"Retina"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/IAE.0000000000004375","article-title":"Pathogenesis, prognosis, and surgical outcomes of full-thickness macular holes in macular telangiectasia type 2: a literature review","volume":"45","author":"Carl\u00e0","year":"2025","unstructured":"6. Carl\u00e0 MM, Cusato M, Hu L, Rizzo S. Pathogenesis, prognosis, and surgical outcomes of full-thickness macular holes in macular telangiectasia type 2: a literature review. Retina. 2025;45:375-382.","journal-title":"Retina"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Gass JD, Blodi BA. Idiopathic juxtafoveolar retinal telangiectasis. Update of classification and follow-up study. Ophthalmology. 1993;100:1536-1546.","DOI":"10.1016\/S0161-6420(93)31447-8"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1167\/iovs.65.11.24","article-title":"Multilayer retinal correspondence of the structural and vascular anomalies in eyes with early macular telangiectasia type 2","volume":"65","author":"Krivosic","year":"2024","unstructured":"8. Krivosic V, Dobbels Z, Duliere C, Zureik A, Tadayoni R, Gaudric A. Multilayer retinal correspondence of the structural and vascular anomalies in eyes with early macular telangiectasia type 2. Invest Ophthalmol Vis Sci. 2024;65:24.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.ophtha.2023.09.016","article-title":"Developing a continuous severity scale for macular telangiectasia type 2 using deep learning and implications for disease grading","volume":"131","author":"Wu","year":"2024","unstructured":"9. Wu Y, Egan C, Olvera-Barrios A, Scheppke L, Peto T, Charbel Issa P, Heeren TFC, Leung I, Rajesh AE, Tufail A, Lee CS, Chew EY, Friedlander M, Lee AY. Developing a continuous severity scale for macular telangiectasia type 2 using deep learning and implications for disease grading. Ophthalmology. 2024;131:219-226.","journal-title":"Ophthalmology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.oret.2021.01.002","article-title":"Prevalence and severity of diabetic retinopathy in patients with macular telangiectasia type 2","volume":"5","author":"van Romunde","year":"2021","unstructured":"10. van Romunde SHM, van der Sommen CM, Martinez Ciriano JP, Vingerling JR, Yzer S. Prevalence and severity of diabetic retinopathy in patients with macular telangiectasia type 2. Ophthalmol Retina. 2021;5:999-1004.","journal-title":"Ophthalmol Retina"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1097\/IAE.0000000000003851","article-title":"Fluorescence lifetime imaging ophthalmoscopy in patients with macular telangiectasia type 2 with and without diabetes","volume":"43","author":"Sauer","year":"2023","unstructured":"11. Sauer L, Vitale AS, Jacoby RS, Hart B, Bernstein PS. Fluorescence lifetime imaging ophthalmoscopy in patients with macular telangiectasia type 2 with and without diabetes. Retina. 2023;43:1597-1607.","journal-title":"Retina"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Clemons TE, Gillies MC, Chew EY, Bird AC, Peto T, Wang JJ, Mitchell P, Ramdas WD, Vingerling JR; Macular Telangiectasia Project Research Group. Medical characteristics of patients with macular telangiectasia type 2 (MacTel type 2) MacTel project report no. 3. Ophthalmic Epidemiol. 2013;20:109-113.","DOI":"10.3109\/09286586.2013.766757"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2147\/OPTH.S373538","article-title":"Macular telangiectasia type 2: a comprehensive review","volume":"16","author":"Kedarisetti","year":"2022","unstructured":"13. Kedarisetti KC, Narayanan R, Stewart MW, Reddy Gurram N, Khanani AM. Macular telangiectasia type 2: a comprehensive review. Clin Ophthalmol. 2022;16:3297-3309.","journal-title":"Clin Ophthalmol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1136\/bjophthalmol-2018-313364","article-title":"Right-angled vessels in macular telangiectasia type 2","volume":"105","author":"Tzaridis","year":"2021","unstructured":"14. Tzaridis S, Heeren T, Mai C, Thiele S, Holz FG, Charbel Issa P, Herrmann P. Right-angled vessels in macular telangiectasia type 2. Br J Ophthalmol. 2021;105:1289-1296.","journal-title":"Br J Ophthalmol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"17198","DOI":"10.1038\/s41598-021-96789-4","article-title":"Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography","volume":"11","author":"Chung","year":"2021","unstructured":"15. Chung YR, Kim YH, Oh J, Kim SW, Lee CS, Yun C, Lee B, Ahn SM, Choi EY, Jang S, Lee K. Characterizing right-angled vessel in macular telangiectasia type 2 with structural optical coherence tomography. Sci Rep. 2021;11:17198.","journal-title":"Sci Rep"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Chandran K, Giridhar A, Desai S, Gopalakrishnan M, Indu VP, Sivaprasad S. Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics. Indian J Ophthalmol. 2024;72(Suppl 1):125-134.","DOI":"10.4103\/IJO.IJO_78_23"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1097\/IAE.0000000000004079","article-title":"From outer retinal neovacularization to exudative subretinal neovascularization in macular telangiectasia type 2","volume":"44","author":"Krivosic","year":"2024","unstructured":"17. Krivosic V, Zureik A, Tadayoni R, Gaudric A. From outer retinal neovacularization to exudative subretinal neovascularization in macular telangiectasia type 2. Retina. 2024;44:1217-1223.","journal-title":"Retina"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1097\/IAE.0000000000001035","article-title":"Long-term outcomes of intravitreal bevacizumab therapy for subretinal neovascularization secondary to idiopathic macular telangiectasia type 2","volume":"36","author":"Toygar","year":"2016","unstructured":"18. Toygar O, Guess MG, Youssef DS, Miller DM. Long-term outcomes of intravitreal bevacizumab therapy for subretinal neovascularization secondary to idiopathic macular telangiectasia type 2. Retina. 2016;36:2150-2157.","journal-title":"Retina"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.4274\/tjo.galenos.2021.75608","article-title":"Clinical features of untreated type 2 macular telangiectasia and efficacy of anti-vascular endothelial growth factor therapy in macular neovascularization","volume":"52","author":"\u00c7oban Karata\u015f","year":"2022","unstructured":"19. \u00c7oban Karata\u015f M, Y\u0131lmaz G, Y\u00fcce Sezen A, Sar\u0131t\u00fcrk \u00c7. Clinical features of untreated type 2 macular telangiectasia and efficacy of anti-vascular endothelial growth factor therapy in macular neovascularization. Turk J Ophthalmol. 2022;52:45-49.","journal-title":"Turk J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1097\/IAE.0000000000004249","article-title":"Comparison of surgical outcomes of macular telangiectasia type 2-associated macular hole with idiopathic macular hole: a tertiary center review","volume":"44","author":"Lee","year":"2024","unstructured":"20. Lee JH, Kim JY, Hwang BE, Kim JY, Kim RY, Kim M, Park YG, Park YH. Comparison of surgical outcomes of macular telangiectasia type 2-associated macular hole with idiopathic macular hole: a tertiary center review. Retina. 2024;44:2076-2085.","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ophtha.2023.08.025","article-title":"Surgical management of full-thickness macular holes in macular telangiectasia type 2: a global multicenter study","volume":"131","author":"Park","year":"2024","unstructured":"21. Park JG, Adrean SD, Begaj T, Capone A Jr, Charles S, Chen SN, Chou HD, Cohen MN, Corona ST, Faia LJ, Garg SJ, Garretson BR, Gregori NZ, Haller JA, Houghton OM, Hsu J, Jo J, Kaiser RS, Lai CC, Mahgoub MM, Mansoor M, Matoba R, Morizane Y, Nehemy MB, Raphaelian PV, Regillo CD, Ruby AJ, Runner MM, Sneed SR, Sohn EH, Spirn MJ, Vander JF, Wakabayashi T, Wolfe JD, Wykoff CC, Yonekawa Y, Yoon YH, Mahmoud TH. Surgical management of full-thickness macular holes in macular telangiectasia type 2: a global multicenter study. Ophthalmology. 2024;131:66-77.","journal-title":"Ophthalmology"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:28:04Z","timestamp":1756121284000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oftalmoloji.org\/articles\/macular-telangiectasia-type-2-long-term-disease-progression-and-management-of-complications\/doi\/tjo.galenos.2025.19940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8,21]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2025.19940","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"value":"1300-0659","type":"print"},{"value":"2147-2661","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]}}}